Skip to main content
. 2022 Nov 2;13:1008755. doi: 10.3389/fphar.2022.1008755

TABLE 2.

Thyroid function changes during neoadjuvant therapy cycles.

T3(nmol/L) T4(nmol/L) FT3(pmol/L) FT4(pmol/L) TSH(uIU/ml) TG (ng/ml) TgAb(U/ml) TPOAb(U/ml)
FC 1.35 114.1 4.88 17.28 3.15 15.5 20.7 <28
SC 1.94 104.1 4.88 11.65 8.13 26 16.9 35.4
TC 1.76 116.9 4.29 12.83 12.638 36.2 <15 41.1

FC, first circle; SC, second circle; TC, third circle.